Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Objective To determine the epidemiological and clinical significance of invasive fungal infections in non-neutropenic patients in intensive care who stay longer than 10 days on the intensive care unit (ICU).Design Prospective epidemiological multicenter study over a period of 11 months, based on strict clinical, bacteriological, serological and histological criteria.Setting Six surgical and two medical ICUs units in five university and two municipal hospitals.Patients 435 non-neutropenic patients from medical and surgical ICUs with an ICU stay of more than 10 days.Measurements and main results A new occurrence of invasive mycosis (3 sepsis/4 peritonitis/1 disseminated candidiasis), corresponding to the protocol conditions with onset after day 10 in the ICU, was detectable in 2.0% (95% confidence interval 0.85 to 3.8%) of the 409 patients who could be assessed. Candida species were identified as an infection-relevant pathogen in all cases. The most important risk factor for the development of an invasive mycosis was the onset of peritonitis by the day 11 in the ICU (odds ratio 11.3; p = 0.003). A fungal colonization was detected in 64% of patients (Candida species 56%, Aspergillus 4%, and other fungi). Six of 8 patients with an invasive mycosis died on the ICU; ICU mortality in patients with fungal colonization was 31% and in noncolonized patients 26%. Serological tests were not helpful clinically. The sensitivity was 88% for the Candida HAT (haemagglutination test) (threshold titer > 1:160), 100% for the Candida IFT (immunofluorescence test) (threshold titer > 1:80), and 50% for the Candida Antigen Test (Candtec Ramco, threshold titer > or = 1:8), and the specificity was 26, 6, and 73%, respectively. The specificity for the Aspergillus HAT (threshold titer > 1:10) was 29%.Conclusions Invasive mycoses are rare in non-neutropenic ICU patients, even after a longer stay in the intensive care unit; fungal colonization, on the other hand, is frequently detectable. The mortality of invasive mycosis--even with systemic antimycotic therapy--was high; the mortality in patients with fungal colonization was not significantly increased compared to that in noncolonized patients. The serological test procedures, Candida HAT, Candida IFT, and the Candida Ramco Antigen Test, had a low specificity and were not helpful in diagnosing relevant invasive mycosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An earlier study by Petri et al. [43] showed that 64% of ICU patients were colonized, and that all infected patients had been previously colonized.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [43]
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 1×
“Other studies using uni- and multivariate analyses for the risk of invasive mycoses in medical and surgical patients describe different risk factors with varying reference and significance: previous antibiotic treatments, isolation of Candida species in several body regions apart from the blood, duration of mechanical…”
Result(1999) · Burn Care · doi:10.1201/9781498713979-15 · Cited by 819
Fungal infections complicating acute leukemia
Bodey, G. P. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90066-x · Cited by 521
Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of Therapy
Horn, R., Wong, B., Kiehn, T. E., & Armstrong, D. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.5.646 · Cited by 480
Fungemia in the immunocompromised host
Meunier-Carpentier, F., Kiehn, T. E., & Armstrong, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90162-5 · Cited by 463
Cited by
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Invasive aspergillosis in critically ill patients without malignancy
Meersseman, W., Vandecasteele, S. J., Wilmer, A., Verbeken, E., Peetermans, W. E., & Van Wijngaerden, E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-093oc · Cited by 547
Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M., De Laere, E., Dimopoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 405
“Although IA has been considered a rare condition among critically ill patients [10-12], recent data indicate that it should be reconsidered as an emerging and devastating infectious disease in this population.”
BackgroundThe changing face of epidemiology of invasive fungal disease in Europe
Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 369
Cornillet, A., Camus, C., Nimubona, S., Gandemer, V., Tattevin, P., Belleguic, C., Chevrier, S., Meunier, C., Lebert, C., Aupee, M., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505870 · Cited by 361
Garnacho-Montero, J., Amaya-Villar, R., Ortiz-Leyba, C., León, C., Álvarez-Lerma, F., Nolla-Salas, J., Iruretagoyena, J. R., & Barcenilla, F. (2005) · Critical Care · doi:10.1186/cc3488 · Cited by 252
“In contrast, in a study conducted Petri and coworkers [18] in 435 non-neutropenic ICU patients, fungal colonization with Aspergillus spp.”
ResultGarbino, J., Lew, D. P., Romand, J.-A., Hugonnet, S., Auckenthaler, R., & Pittet, D. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1540-y · Cited by 246
“with high overall (35–80%) and attributable (30–40%) mortality [5, 6, 7, 9, 12, 13].”
BackgroundPiarroux, R., Grenouillet, F., Balvay, P., Tran, V., Blasco, G., Millon, L., & Boillot, A. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147726.62304.7f · Cited by 216
“of proven acquired candidiasis in the control group, which is in agreement with the literature (6, 25, 26).”
ResultCandida Urinary Tract Infections—Treatment
Fisher, J. F., Sobel, J. D., Kauffman, C. A., & Newman, C. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir112 · Cited by 215
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial
Schuster, M. G., Edwards, J. E., Sobel, J. D., Darouiche, R. O., Karchmer, A. W., Hadley, S., Slotman, G., Panzer, H., Biswas, P., & Rex, J. H. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00004 · Cited by 210
“Any adverse event 133 (100) 135 (99) Adverse event related to study drug* 14 (11) 20 (15) Treatment stopped because of adverse event 7 (5) 10 (7) Treatment stopped because of abnormal test results associated with liver function 3 (2) 5 (4)”
BackgroundMontravers, P., Mira, J.-P., Gangneux, J.-P., Leroy, O., & Lortholary, O. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03360.x · Cited by 206
Marik, P. E. (2000) · Chest · doi:10.1378/chest.117.3.855 · Cited by 195
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. ‐., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · German medical science · doi:10.18154/rwth-conv-061584 · Cited by 193
Self-citationPaphitou, N. I., Ostrosky-Zeichner, L., & Rex, J. H. (2005) · Medical Mycology · doi:10.1080/13693780410001731619 · Cited by 179
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173
“[43] showed that 64% of ICU patients were colonized, and that all infected patients had been previously colonized.”
BackgroundCandida spp. colonization significance in critically ill medical patients: a prospective study
Charles, P. E., Dalle, F., Aube, H., Doise, J. M., Quenot, J. P., Aho, L. S., Chavanet, P., & Blettery, B. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2571-y · Cited by 170
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki491 · Cited by 159
Diagnosis of invasive candidiasis in the ICU
Eggimann, P., Bille, J., & Marchetti, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-37 · Cited by 131
“in semiquantitative cultures from multiple sites has been found to predict the subsequent development of invasive candidiasis [21,52,53].”
BackgroundProphylactic antifungal therapy in the intensive care unit
Weinstein, R. A., Rex, J. H., & Sobel, J. D. (2001) · Clinical Infectious Diseases · doi:10.1086/319763 · Cited by 155
Risk factors for albicans and non-albicans candidemia in the intensive care unit*
Chow, J. K., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D. A., Chawla, V., Young, J. A., & Hadley, S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31816fc4cd · Cited by 154
Positive Fungal Cultures in Burn Patients: A Multicenter Review
Ballard, J., Edelman, L., Saffle, J., Sheridan, R., Kagan, R., Bracco, D., Cancio, L., Cairns, B., Baker, R., Fillari, P., et al. (2008) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e31815f6ecb · Cited by 143
“Recent specific definitions for burn wound infections rely heavily on wound appearance; fungal infections, in contrast, are notoriously difficult to diagnose on clinical evidence alone.(20) Finally, burn centers differ widely in their practices for wound care, thresholds for obtaining cultures, performance of surveill…”
BackgroundReinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1719-5 · Cited by 148
Self-citationEconomic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient
Jord�, R., Nolla‐Salas, J., Le�n-Regidor, M. A., lvarez-Lerma, F., Olaechea, P., Palomar, M., & Le�n-Gil, C. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1104-x · Cited by 145
Candidemia in Finland, 1995–1999
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., & Ruutu, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030069 · Cited by 121
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · BORIS (University Library Bern) · doi:10.48350/654 · Cited by 137
Self-citationDiagnosis of infection in sepsis: An evidence-based review
Cohen, J., Brun‐Buisson, C., Torres, A., & Jorgensen, J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145917.89975.f5 · Cited by 136
Usami, M., Ohata, A., Horiuchi, T., Nagasawa, K., Wakabayashi, T., & Tanaka, S. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00162.x · Cited by 117
Cruciani, M., de Lalla, F., & Mengoli, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2794-y · Cited by 127
“Although several reports from the United States and Europe show that Candida bloodstream infection remains a relatively rare event in critically ill patients, with an incidence of one case or less per 1,000 ICU admission [1, 2, 5, 6], rates of Candida bloodstrem infection have increased steadily, and incidence as high…”
Candidemia in critically ill patients: difference of outcome between medical and surgical patients
Charles, P., Doise, J. M., Quenot, J., Aube, H., Dalle, F., Chavanet, P., Milési, N., Aho, S., Portier, H., & Blettery, B. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-2002-x · Cited by 121
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 118
Risk factors for candidaemia in critically ill patients: a prospective surveillance study*
Jordà‐Marcos, R., Álvarez‐Lerma, F., Jurado, M., Palomar, M., Nolla‐Salas, J., León, M. A., León, C., & the EPCAN Study Group (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01366.x · Cited by 95
Bernardes‐Engemann, A. R., Orofino‐Costa, R., Miguens, B. P., y Penha, C. V. L., Neves, E., Pereira, B. A. S., Dias, C. M. P., Mattos, M., Gutierrez, M. C., Schubach, A., et al. (2005) · Medical Mycology · doi:10.1080/13693780400019909 · Cited by 99
Golan, Y., Wolf, M. P., Pauker, S. G., Wong, J. B., & Hadley, S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00004 · Cited by 95
“rates are observed in patients in the ICU (7, 13, 86), but reported”
BackgroundIsolation of Aspergillus in critically ill patients: a potential marker of poor outcome
Khasawneh, F. A., Mohamad, T. N., Moughrabieh, M. K., Lai, Z., Ager, J. W., & Soubani, A. O. (2006) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.03.006 · Cited by 96
Potential risk factors for infection with Candida spp. in critically ill patients
Bota, D. P., Rodriguez‐Villalobos, H., Dimopoulos, G., Mélot, C., & Vincent, J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00873.x · Cited by 95
Candida colonization and candidemia in a pediatric intensive care unit
Singhi, S. C., Rao, D. S. V. R., & Chakrabarti, A. (2008) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000298643.48547.83 · Cited by 93
Agvald-Öhman, C., Klingspor, L., Hjelmqvist, H., & Edlund, C. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534509 · Cited by 87
León, C., Álvarez-Lerma, F., Ruiz‐Santana, S., de Leon, M. A. M., Nolla‐Salas, J., Jordà, R., Saavedra, P., Palomar, M., & The EPCAN Study Group (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0618-z · Cited by 86
“[17] determined the significance of fungal infections in nonneutropenic patients in intensive care who stayed for longer than 10 days in eight ICUs.”
InfluentialSilvestri, L., SAENE, H. K. F. V., Milanese, M., & Gregori, D. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2654-9 · Cited by 78
“Data over the past two decades indicate that invasive candidiasis in critically ill, non-immunosuppressed patients is of increasing importance [12, 13 ].”
BackgroundDiagnosis of infection in sepsis
Llewelyn, M., & Cohen, J. D. (2001) · Intensive Care Medicine · doi:10.1007/pl00003792 · Cited by 78
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
Host-Based Peripheral Blood Gene Expression Analysis for Diagnosis of Infectious Diseases
Holcomb, Z. E., Tsalik, E. L., Woods, C. W., & McClain, M. T. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01057-16 · Cited by 75
“For example, host-based gene expression has been proven to be able to distinguish active infection from colonization (7), to distinguish among broad pathogen classes (such as distinguishing viral from bacterial pathogens), and to provide prognostic information and disease severity prediction (8, 9).”
BackgroundManagement of candidiasis in the intensive care unit
Schelenz, S. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm430 · Cited by 69
“In SICU patients, the most frequently colonized sites are the oropharynx (63%), urine (25%) and gut (11%), but Candida can also be found in other areas such as the lumen of medical devices including urinary catheters and wound drains.(16) The risk of colonization increases with the duration of the ICU stay, the use of…”
BackgroundAl-Dorzi, H. M., Sakkijha, H., Khan, R., Aldabbagh, T., Toledo, A., Ntinika, P., Al Johani, S. M., & Arabi, Y. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066618767835 · Cited by 61
Current diagnostic approaches to invasive candidiasis in critical care settings
Pemán, J., & Zaragoza, R. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01732.x · Cited by 68
Fungal infection in the intensive care unit
Flanagan, P., & Barnes, R. A. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90271-7 · Cited by 67
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
“The genus Candida is an extremely diverse group of fungal organisms, but only a few are involved in developing superficial and invasive infections that are spread worldwide [1,2].”
BackgroundRapid identification of Candida spp. in peritonitis patients by Raman spectroscopy
Ibelings, M. S., Maquelin, K., Endtz, H. P., Bruining, H. A., & Puppels, G. J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01103.x · Cited by 65
Candida in Burns: Risk Factors and Outcomes
Moore, E. C., Padiglione, A. A., Wasiak, J., Paul, E. M., & Cleland, H. J. (2010) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181d0f536 · Cited by 65
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Disseminated Nosocomial Fungal Infection by Aureobasidium pullulans var. melanigenum : a Case Report
Bolignano, G., & Criseo, G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4483-4485.2003 · Cited by 63
Infection in the chronically critically ill: unique risk profile in a newly defined population
Kalb, T. H., & Lorin, S. M. (2002) · Critical Care Clinics · doi:10.1016/s0749-0704(02)00009-x · Cited by 62
Timsit, J., Schwebel, C., Styfalova, L., Cornet, M., Poirier, P., Forrestier, C., Ruckly, S., Jacob, M., & Souweine, B. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05622-0 · Cited by 60
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Gerlach, H., Gründling, M., Kreymann, G., Kujath, P., Marggraf, G., Mayer, K., Meier‐Hellmann, A., et al. (2006) · Der Internist · doi:10.1007/s00108-006-1595-x · Cited by 60
Self-citationCandida Peritonitis: An Update on the Latest Research and Treatments
Carneiro, H. A., Mavrakis, A., & Mylonakis, E. E. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1305-2 · Cited by 59
“Colonization with Candida species, especially candiduria, hospitalacquired candidemia, especially in the ICU setting, and mechanical ventilation [1, 2, 18, 21, 32]”
BackgroundInfluentialCentral venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 58
Practices in non-neutropenic ICU patients with Candida-positive airway specimens
Azoulay, É., Cohen, Y., Zahar, J., Garrouste-Orgeas, M., Adrie, C., Moine, P., de Lassence, A., & Timsit, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2316-3 · Cited by 57
“Colonisation is an independent risk factor for systemic candidiasis [3, 4, 5].”
BackgroundAntifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub2 · Cited by 52
Stéphan, F., Sialou Bah, M., Desterke, C., Rézaiguia‐Delclaux, S., Foulet, F., Duvaldestin, P., & Bretagne, S. (2002) · Clinical Infectious Diseases · doi:10.1086/344648 · Cited by 56
Harrison, D. A., Muskett, H., Harvey, S. E., Grieve, R., Shahin, J., Patel, K., Sadique, Z., Allen, E., Dybowski, R., Jit, M., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17030 · Cited by 56
Surgical critical care: Fungal infections in surgical patients
Lipsett, P. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000231883.93001.e0 · Cited by 52
Nosocomial Pneumonia: Prevention, Diagnosis, Treatment
Lorenz, J., Bodmann, K. ‐., Bauer, T. T., Ewig, S., Trautmann, M., & Vogel, F. (2003) · Pneumologie · doi:10.1055/s-2003-42217 · Cited by 48
Candida Colonization Index in Patients Admitted to an ICU
Caggiano, G., Puntillo, F., Coretti, C., Giglio, M., Alicino, I., Manca, F., Bruno, F., & Montagna, M. T. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107038 · Cited by 47
“Candida colonization is present in 5–15% of patients but it can achieve peaks of 50–86% and an invasive infection can develop in 5–30% of colonized patients [14,15].”
BackgroundZaragoza, R., Perman, J., Salavert, M., Viudes, Solé, A., Jarque, I., Cantón, R., Monte‐Boquet, E., & Romá, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3994 · Cited by 46
“…antibiotics, parenteral nutrition, multiple lumen catheters, prior Candida spp. colonization, renal replacement therapy, and mechanical ventilation (Petri et al 1997; Blumberg et al 2001; Alvarez-Lerma et al 2003), has become the cornerstone of empiric treatment of fungal infections in the ICU…”
DiNubile, M. J., Lupinacci, R. J., Strohmaier, K. M., Sable, C. A., & Kartsonis, N. A. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.11.004 · Cited by 46
Oral candidiasis in systemic lupus erythematosus
Fangtham, M., Magder, L. S., & Petri, M. (2014) · Lupus · doi:10.1177/0961203314525247 · Cited by 43
Self-citationÁlvarez-Lerma, F., Palomar, M., León, C., Olaechea, P., Cerdá, E., & Bermejo, B. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)73891-3 · Cited by 41
Early diagnosis of candidiasis in non-neutropenic critically ill patients
Ibáñez-Nolla, J., Nolla-Salas, M., de Leon, M. A. M., García, F., Marrugat, J., Soria, G., Dı́az, R. M., & Torres-Rodríguez, J. M. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00120-8 · Cited by 40
Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients
Normand, S., François, B., Dardé, M., Bouteille, B., Bonnivard, M., Preux, P., Gastinne, H., & Vignon, P. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2807-x · Cited by 38
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Gerlach, H., Gründling, M., Kreymann, G., Kujath, P., Marggraf, G., Mayer, K., Meier-Hellmann, A., et al. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0414-7 · Cited by 39
Self-citationBär, W., & Hecker, H. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00709.x · Cited by 35
Pitangui, N. D. S. (2013) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000141 · Cited by 34
“In the hospital environment, patients in intensive care units are the most vulnerable because they are exactly those whose management is done from intravascular catheters, probes bladder and mechanical ventilation, and other invasive methods, which increases the risk of opportunistic infection [23,27].”
BackgroundSwoboda, S., Lichtenstern, C., Ober, M. C., Taylor, L. A., Störzinger, D., Michel, A., Brobeil, A., Mieth, M., Hofer, S., Sonntag, H., et al. (2009) · Chemotherapy · doi:10.1159/000264672 · Cited by 34
“Crude mortality of systemic fungal infections remains very high with an average of more than 50p (range 20–95) [”
BackgroundManagement ofCandidainfections in the adult intensive care unit
Cruciani, M., & Serpelloni, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.175 · Cited by 33
“Crude mortality rates have been estimated in the range 25 – 75% depending on patient age and severity of underlying disease, and the attributable mortality of candidaemia has been estimated to be 5 – 71% [13,14,27-31] .”
BackgroundLipsett, P. A. (2004) · Clinical Infectious Diseases · doi:10.1086/421956 · Cited by 32
Russo, A., Falcone, M., Vena, A., Venditti, C., Mancini, C., Morelli, A., & Venditti, M. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.5.290 · Cited by 32
Disseminated candidiasis secondary to fungal and bacterial peritonitis in a young dog
Rogers, C. L., Gibson, C., Mitchell, S. L., Keating, J. H., & Rozanski, E. A. (2009) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2009.00405.x · Cited by 32
Saturday night fever: finding and controlling the source of sepsis in critical illness
Rizoli, S., & Mashall, J. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00220-7 · Cited by 32
Thorman, R., Neovius, M., & Hylander, B. (2009) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590902836492 · Cited by 31
Identification and management of invasive mycoses in internal medicine: a road-map for physicians
Falcone, M., Concia, E., Iori, I., Cascio, G. L., Mazzone, A., Pea, F., Violi, F., & Venditti, M. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1077-4 · Cited by 30
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. ‐., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-010-0169-2 · Cited by 28
Self-citationEvolving role of early antifungals in the adult intensive care unit
Lam, S. W., Eschenauer, G. A., & Carver, P. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819dec9b · Cited by 28
Pasqualotto, A. C., & Severo, L. C. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01843.x · Cited by 28
Lichtenstern, C., Schmidt, J., Knaebel, H., Martin, E., Büchler, M. W., & Weigand, M. A. (2007) · Digestive Surgery · doi:10.1159/000099009 · Cited by 28
Candidainfections in the intensive care unit: epidemiology, risk factors and therapeutic strategies
Bassetti, M., Righi, E., Tumbarello, M., Biagio, A. D., Rosso, R., & Viscoli, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.875 · Cited by 26
Zaragoza, R., & Pemán, J. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70014-6 · Cited by 25
Awasthi, A. K., Jain, A., Awasthi, S., Ambast, A., Singh, K., & Mishra, V. (2011) · Mycopathologia · doi:10.1007/s11046-011-9431-9 · Cited by 24
Hof, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01522.x · Cited by 22
Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico
Pemán, J., & Zaragoza, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.002 · Cited by 21
The Diagnostic and Therapeutic Approach to Fungal Infections in Critical Care Settings
Zaragoza, R., & Pemán, J. (2008) · Cited by 21
Antifungal agents for preventing fungal infections in non-neutropenic critically-ill patients
Playford, E. G., Webster, A., Sorrell, T. C., & Craig, J. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920 · Cited by 21
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit
Smith, J. A., & Kauffman, C. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cf25 · Cited by 20
Azoulay, É., Limal, N., Mayaud, C. M., & Schlemmer, B. (2001) · Réanimation · doi:10.1016/s1164-6756(01)00120-7 · Cited by 18
Rafik, A., Diouri, M., Bahechar, N., & Chlihi, A. (2016) · PubMed · Cited by 16
Lortholary, O., Charlemagne, A., Bastides, F., Chevalier, P., Datry, A., Gonzalves, M.-F., Michel, G., Tilleul, P., Veber, B., & Herbrecht, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh348 · Cited by 16
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Gerlach, H., Gründling, M., Kreymann, G., Kujath, P., Marggraf, G., Mayer, K., Meier‐Hellmann, A., et al. (2006) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-006-0701-6 · Cited by 16
Self-citationAzoulay, É., Timsit, J., Lautrette, A., Legriel, S., Max, A., Ruckly, S., Misset, B., Cohen, Y., & Wolff, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177093 · Cited by 14
Weis, C., Kappe, R., & Sonntag, H. ‐. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00207.x · Cited by 14
The utility of serology in diagnosing candidosis in non‐neutropenic critically ill patients
Ibáñez-Nolla, J., Jm, T.-R., Nolla, M. D. C., de Leon, M. A. M., Mèndez, R., Soria, G., Díaz, R., & Marrugat, J. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00616.x · Cited by 13
DisseminatedCryptococcus neoformansvar.grubiiinfections in intensive care units
Chuang, Y.-H., Ku, S., Liaw, S., WU, S. C., Ho, Y., Yu, C., & Hsueh, P. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990926 · Cited by 12
Metadata
- Authors
- Petri, M. G., König, J., Moecke, H. P., Gramm, H. J., Barkow, H., Kujath, P., Dennhart, R., Schäfer, H., Meyer, N., Kalmar, P., Thülig, P., Müller, J., & Lode, H.
- Affiliations
- Freie Universität Berlin (DE)
- Heidelberg University (DE)
- Asklepios Klinik Altona (DE)
- Universitätsklinikum Würzburg (DE)
- Krankenhaus Nordwest (DE)
- Universitätsklinik Marien Hospital Herne (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Münster (DE)
- University of Freiburg (DE)
- Venue
- Intensive Care Medicine
- Published
- 1997-03-12
- Volume
- 23
- Issue
- 3
- Pages
- 317-325
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2021610658
- Cited by
- 185
- References
- 31
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive mycosis, invasive fungal infections, non-neutropenic patients, intensive care unit, Candida, peritonitis, fungal colonization, risk factors, mortality, serological diagnosis, Aspergillus, sepsis, systemic candidiasis, ICU length of stay, epidemiology, sensitivity and specificity, histopathology, immunofluorescence
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Female, Germany, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Mycoses, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Chi-Square Distribution, Logistic Models, Hospital Mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.